-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLDEX THERAPEUTICS: BARZOLVOLIMAB WELL TOLERATED; LOADING DOSE FOLLOWED BY Q4W DOSING SHOW FAVORABLE SAFETY PROFILE CONSISTENT WITH PRIOR STUDIES

路透·07/21/2026 20:01:00

登录查看新闻详情